The Effectiveness of Pilates in Women With Lumbar Disc Herniation

December 19, 2025 updated by: Doç.Dr.Ömer Şevgin, Uskudar University

Comparison of the Effects of Reformer Pilates and Mat Pilates on Certain Physical and Functional Parameters in Women With Lumbar Disc Herniation

The aim of the study was to compare the effects of reformer pilates and mat exercise on pain, quality of life and kinesiophobia in female patients with lumbar disc herniation.

Study Overview

Detailed Description

The study began with patients diagnosed with lumbar disc herniation. Individuals were invited to participate based on inclusion criteria. Exclusion criteria were used to exclude individuals. Individuals were evaluated twice in this study. Treatment methods were applied. Mat Pilates was applied to one of the diagnosed groups, and reformer Pilates was applied to the other. Twenty participants were assigned to the mat Pilates group and 20 to the equipment Pilates group. A total of 40 patients participated. Pre- and post-treatment assessments were conducted using the Tampa Kinesiophobia Scale, Short Form Quality of Life Scale, and Visual Analog Scale.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kadıköy
      • Istanbul, Kadıköy, Turkey (Türkiye)
        • Fone Physio Healthy Living Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  • Being between 25 and 60 years of age
  • Having been diagnosed with a lumbar disc herniation
  • Having agreed to participate in the study

Exclusion Criteria

  • Being outside the specified age limits
  • Having an orthopedic, neurological, or other condition that prevents exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: mat exercise group
mat pilates exercise
The mat pilates group was given an exercise program consisting of 16 sessions, 2 days a week, for 8 weeks. All exercises were performed as one set of 15 repetitions for the first 2 weeks, 15 repetitions for the 3rd and 4th weeks, and 15 repetitions for the 5th and 6th weeks, with 20 repetitions for the final 2 weeks. Exercise intensity (number of repetitions and level of movement) was gradually increased. Priority was given to core muscles when selecting exercises. The aim was to work the transversus abdominis, multifidus, and gluteus muscles both eccentrically and concentrically, while maintaining spinal stabilization and fostering awareness during movement. The exercise protocol was performed twice a week for 8 weeks, with each session lasting 45 minutes.
Experimental: reformer exercise group
reformer pilates exercise
The Reformer Pilates group was assigned an exercise program consisting of 16 sessions, 2 days a week, for 8 weeks. All exercises were performed as one set of 15 repetitions for the first 2 weeks, 15 repetitions for the 3rd and 4th weeks, and 20 repetitions for the 5th and 6th weeks. Exercise intensity (number of repetitions and level of movement) was gradually increased. Priority was given to core muscles when selecting exercises. The aim was to work the transversus abdominis, multifidus, and gluteus muscles both eccentrically and concentrically, while maintaining spinal stabilization and fostering awareness during movement. The exercise protocol consisted of 45-minute sessions, 2 days a week, for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
quality of life scale short form
Time Frame: 10 weeks
The scale assessing quality of life consists of 36 questions. It rates health on a scale of 0 to 100, with 0 indicating poor health and 100 indicating good health.
10 weeks
Tampa Kinesiophobia Scale
Time Frame: 10 weeks
The scale consists of 17 questions. It includes parameters for injury/re-injury and fear-avoidance in work-related activities. Each question is scored using a 4-point Likert scale (1 = strongly disagree, 4 = strongly agree). A total score is calculated by reverse-scoring questions 4, 8, 12, and 16. A higher score is interpreted as indicating a higher level of kinesiophobia.
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ayça Bilgi, Uskudar University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 5, 2024

Primary Completion (Actual)

March 15, 2024

Study Completion (Actual)

May 10, 2024

Study Registration Dates

First Submitted

November 21, 2025

First Submitted That Met QC Criteria

November 21, 2025

First Posted (Estimated)

December 3, 2025

Study Record Updates

Last Update Posted (Actual)

December 29, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on mat pilates

Subscribe